http://www.asm.org/index.php/asm-newsroom/press-releases/92-news-room/press-releases/91734-h7n9-influenza-strain-resistant-to-antivirals-but-tests-fail-to-identify-resistance
Posted by Rob LW
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment